4.6 Review

Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration

Journal

JOURNAL OF LIPID RESEARCH
Volume 51, Issue 3, Pages 451-467

Publisher

ELSEVIER
DOI: 10.1194/jlr.R002238

Keywords

retinal pigment epithelium; Bruch's membrane; drusen; basal deposits; cholesterol; retinyl ester

Funding

  1. National Institutes of Health [EY06109, EY014662]
  2. International Retinal Research Foundation
  3. American Health Assistance Foundation
  4. EyeSight Foundation of Alabama
  5. Research to Prevent Blindness, Inc.
  6. Macula Vision Research Foundation
  7. Roger Johnson Prize in Macular Degeneration Research
  8. Deutsche Forschungsgemeinschaft
  9. NATIONAL EYE INSTITUTE [R01EY014662, R01EY006109] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The largest risk factor for age-related macular degeneration (ARMD) is advanced age. With aging, there is a striking accumulation of neutral lipids in Bruch's membrane (BrM) of normal eye that continues through adulthood. This accumulation has the potential to significantly impact the physiology of the retinal pigment epithelium (RPE). It also ultimately leads to the creation of a lipid wall at the same locations where drusen and basal linear deposit, the pathognomonic extracellular, lipid-containing lesions of ARMD, subsequently form. Here, we summarize evidence obtained from light microscopy, ultrastructural studies, lipid histochemistry, assay of isolated lipoproteins, and gene expression analysis. These studies suggest that lipid deposition in BrM is at least partially due to accumulation of esterified cholesterol-rich, apolipoprotein B-containing lipoprotein particles produced by the RPE. Furthermore, we suggest that the formation of ARMD lesions and their aftermath may be a pathological response to the retention of a subendothelial apolipoprotein B lipoprotein, similar to a widely accepted model of atherosclerotic coronary artery disease (Tabas, I., K.J. Williams, and J. Boren. 2007. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 116: 1832-1844). This view provides a conceptual basis for the development of novel treatments that may benefit ARMD patients in the future.-Curcio, C. A., M. Johnson, J-D. Huang, and M. Rudolf. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J. Lipid Res. 2010. 51: 451-467.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available